Slides
Page 1
COMPANY PRESENTATION Conference Call Q1 2025 Financial results May 16th , 2025
Page 2
Certain statements in this slide show,including those addressing the Company’sbeliefs,plans, objectives,estimates or expectations of possible future results or events, are forward-looking statements. Forward-looking statements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof. 2DISCLAIMER
Page 3
HIGHLIGHTS – Q1 2025 3 P&L 31/03/2024 % 31/03/2025 % Var.% unaudited unaudited Revenues 129.555 140.900 8,8% EBIT 15.544 12,0% 17.410 12,4% 12,0% Revenues 31/03/2024 % 31/03/2025 % Var.% Medical 91.704 70,8% 99.204 70,4% 8,2% Industrial 37.850 29,2% 41.696 29,6% 10,2%
Page 4
INCOME STATEMENT – Q1 2025 4 Euro '000 31/03/2024 % 31/03/2025 % Var. % unaudited unaudited Medical 91.704 70,8% 99.204 70,4% 8,2% Industrial 37.850 29,2% 41.696 29,6% 10,2% Revenues 129.555 100,0% 140.900 100,0% 8,8% Gross margin 57.680 44,5% 62.947 44,7% 9,1% Operating Expenses 14.368 11,1% 15.132 10,7% 5,3% Staff espenses 23.395 18,1% 26.088 18,5% 11,5% EBITDA 19.917 15,4% 21.726 15,4% 9,1% Depr., amort., accruals 4.372 3,4% 4.316 3,1% -1,3% EBIT 15.544 12,0% 17.410 12,4% 12,0% Net financ.income(charges) 423 0,3% (1.111) -0,8% Other income (expense) net (14) 0,0% 19 0,0% EBT 15.954 12,3% 16.318 11,6% 2,3% 31/12/24 31/03/25 unaudited Net financial position 110.559 107.558
Page 5
6 mln Cash Flow – FY 2024 5 8 mln * Nopat =Ebit-Income tax **D&A= Depreciation, Accruals and Devaluation ***NWC= Net Working Capital
Page 6
Revenue Breakdown by Business 6 Medical: +8% Industrial: +10% in Euro million +9% +9% +13% +6% +9% -33% 0% +14%
Page 7
Revenue Breakdown by Area 7 in Euro million +54% +3% +17% +8% +18% -5% Medical: +8% Industrial: +10%
Page 8
2025 Guidance 8 Revenues 2025 > Revenues 2024 EBIT 2025 > EBIT 2024
Page 9
CONTACTS El.En. S.P.A. Enrico Romagnoli Investor Relations Manager tel. +39 055-8826807 E-mail: finance@elen.it POLYTEMS HIR Financial Communication, IR and Press Office Bianca Fersini Mastelloni - b.fersini@polytemshir.it Silvia Marongiu - s.marongiu@polytemshir.it Tel. +39 06-69923324